Aom-0821

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAom-0821
Drug Alias Nameplatelet aggregation inhibitor (Hangzhou Adamerck)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor inhibitors
TargetsCoagulation factor
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesHangzhou Adamerck Pharmlabs Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHangzhou Adamerck Pharmlabs Inc
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A